Introduction {#s01}
============

Macrophages (Mfs) are mononuclear phagocytes resident in most tissues where they perform vital functions in defense against pathogens, maintenance of tissue homeostasis, and wound repair ([@bib10]; [@bib61]). Traditionally, peripheral blood monocytes (PBMos) have been viewed as precursors of resident tissue Mfs ([@bib60]). However, recent studies in mice have demonstrated that in many organs Mfs are populations of self-renewing cells, established before birth from yolk sac-- or fetal liver--derived precursors and independent of bone marrow--derived PBMos ([@bib50]; [@bib19]; [@bib52]; [@bib20]). Studies on the origin of Mfs in humans are scarce ([@bib17]); however, we have reported recently that donor alveolar Mfs in transplanted lungs were maintained for years ([@bib12]), indicating that self-renewing resident Mfs also occur in humans.

Mfs in the mouse intestine have been reported to be an exception from this paradigm. It has been shown that during steady-state Ly6C^hi^ PBMos expressing low levels of CX3CR1 constantly migrate to the intestinal lamina propria of mice in a CCR2-dependent manner, where they differentiate into resident mature CX3CR1^hi^ Mfs with antiinflammatory properties through a series of short-lived CX3CR1^int^ intermediaries ([@bib58]; [@bib1], [@bib2]).

We have previously shown that the majority of HLA-DR^+^ mononuclear phagocytes in human small intestine (SI) were mature Mfs expressing CD14, CD68, CD163, and CD209 (DC-SIGN) but negative for CD11c and CCR2, whereas a minor population expressed CD1c and CD11c compatible with being dendritic cells (DCs; [@bib40]; [@bib3], [@bib4]). A less pronounced population coexpressed CD14 and CD11c, and most of these cells were also CCR2^+^, indicating that they were recently recruited PBMos ([@bib4]). Importantly, the CD11c^+^CD14^+^CCR2^+^ population was selectively expanded in the intestinal mucosa of celiac disease patients after gluten challenge, suggesting that they were increasingly recruited to SI during local inflammation ([@bib4]). Moreover, other studies of inflammation in the human gut have shown that recently elicited CD14^+^ PBMos, in contrast to tissue-resident regulatory Mfs, produce proinflammatory cytokines ([@bib45]; [@bib23]). However, a comprehensive analysis of Mfs in steady-state human intestine is lacking, and the developmental relationship between PBMos and intestinal Mfs is still unclear.

By extensive phenotyping, transcriptome profiling, and functional analysis of tissue HLA-DR^+^ mononuclear phagocytes, we demonstrated here that under steady-state conditions human SI harbors four CD14^+^ Mf subsets that are distinct from DCs. Examining the replacement kinetics of Mfs in transplanted intestine showed that all Mf subsets were replaced by blood-derived precursors within one year after transplantation.

Results {#s02}
=======

Human SI contains four distinct subsets of Mfs {#s03}
----------------------------------------------

Flow cytometric analysis of single-cell suspensions from mucosa of duodenal-proximal jejunum (SI) revealed three distinct populations of HLA-DR^+^CD45^+^ cells that differentially expressed CD14 and CD11c ([Fig. 1 A](#fig1){ref-type="fig"} and Fig. S1 A). CD14^+^CD11c^−^ Mfs have been shown to comprise the majority of HLA-DR^+^ cells in human SI ([@bib3]), and the CD14^+^CD11c^+^ population was previously shown to expand in patients with celiac disease when challenged with gluten, and based on phenotype it was suggested as deriving from PBMos ([@bib4]). We identified two subsets within the CD14^+^CD11c^+^ (CD11c^+^ Mf) gate based on their differential expression levels of HLA-DR and CD14 ([Fig. 1 A](#fig1){ref-type="fig"}, top right), whereas two populations could be identified within the CD14^+^CD11c^−^ (CD11c^−^ Mf) gate based on their differential expression of CD11b ([Fig. 1 A](#fig1){ref-type="fig"}, bottom right). The subsets were designated Mf1 (CD14^+^CD11c^+^HLA-DR^int^), Mf2 (CD14^+^CD11c^+^HLA-DR^hi^), Mf3 (CD14^+^CD11c^−^CD11b^−^), and Mf4 (CD14^hi^CD11c^−^CD11b^+^). These populations were readily distinguished from DCs that expressed CD11c but not CD14 ([Fig. 1 A](#fig1){ref-type="fig"}). Mf3 constituted the majority of CD45^+^HLA-DR^+^ cells (median 60.7%), whereas lower numbers of Mf1 (4.7%), Mf2 (11.6%), Mf4 (14.4%), and DCs (5.5%) were found ([Fig. 1 B](#fig1){ref-type="fig"}). Both Mf1 and Mf2 populations displayed smaller size and lower autofluorescence than Mf3 and Mf4 and had morphology similar to PBMos, including kidney-shaped nuclei, whereas Mf3 and particularly Mf4 had distinctly shaped nuclei, more cytoplasm, and autofluorescence, characteristic of mature Mfs ([Fig. 1, C and D](#fig1){ref-type="fig"}). We then compared phenotypes of SI Mfs and DCs with CD14^+^ PBMos and blood DCs (PBDCs) by flow cytometry ([Fig. 1 E](#fig1){ref-type="fig"} and Fig. S1 B). CD64, MerTK, CD163, CD16, SIRPα, and CD115 were consistently expressed on all four SI Mf subsets, although at varying levels. CX3CR1 was expressed on Mf1, Mf2, and CD14^+^ PBMos. Low CX3CR1 levels on Mf3 and Mf4 and its expression on a subset of DCs in tissue and blood was consistent with a previous study on skin ([@bib32]). CD206 was not expressed on CD14^+^ PBMos and was nearly absent on Mf1, but high levels were detected on the other Mf populations. Intestinal DCs did not express CD163 or CD16 and expressed low levels of CD64, CD115, and MerTK and variable levels of CD11b, SIRPα, CD206, CD1c, and CD103 ([Fig. 1 E](#fig1){ref-type="fig"}). Expression of markers on PBDCs was largely similar, although CD163 and CD115 were detected on a subset of PBDCs, and CD206 and CD103 were not expressed ([Fig. 1 E](#fig1){ref-type="fig"}). Low levels of CD1c were detected on Mf1 and CD14^+^ PBMos, as shown previously ([@bib49]; [@bib6]), whereas higher levels were detected on Mf2. CD103 was dimly expressed on a subset of Mf2 ([Fig. 1 E](#fig1){ref-type="fig"}), compatible with reported in vitro induction of this marker on PBMos or PBMo-derived DCs by TGF-β and retinoic acid ([@bib49]; [@bib43]), which are both abundant in the intestinal mucosa ([@bib18]; [@bib11]; [@bib34]).

![**Human SI contains four distinct Mf subsets. (A)** Representative flow cytometric analysis of human SI Mfs, identifying Mf1 (purple) and Mf2 (green, top right), Mf3 (red), and Mf4 (blue, bottom right), and DCs (pink, top center) among CD45^+^HLA-DR^+^ SI mononuclear phagocytes. Arrows indicate sequential gating (see Fig. S1 A for extended gating strategy). Dot plots are representative of all subjects. **(B)** The proportion of SI mononuclear phagocyte subsets given as percentage of all Mfs and DCs (CD45^+^HLA-DR^+^) was determined by flow cytometry; bars indicate median values (*n* = 55). **(C)** Representative micrographs of SI Mf subsets sorted by flow cytometry and stained with Hemacolor reagent. *n* = 2. Bars, 5 µm. **(D)** Representative dot plots showing FSC-A (size), SSC-A (granularity), and autofluorescence of SI Mf subsets and DCs. Autofluorescence was measured as fluorescence excited by a 488-nm laser and collected by a 530/30 bandpass filter, where matched fluorochrome was not included. Data are representative of all subjects. **(E)** Representative flow cytometric staining of surface markers on PBDC, CD14^+^ PBMo (*n* = 3 or more; gated as in Fig. S1 B), and SI Mf subsets and DCs (*n* = 4 or more). Gray histograms represent FMO controls.](JEM_20170057_Fig1){#fig1}

To control for possible coisolation of PBMos, we performed tissue digestion with the addition of sorted, CFSE-labeled CD14^+^ PBMos (CFSE-PBMos; Fig. S1 C; [@bib32]). Flow cytometric analysis of single-cell suspensions showed that CFSE-PBMos and Mf1 exhibited very similar immunophenotypes (Fig. S1 D), but higher expression of HLA-DR, HLA-DQ, CD64, MerTK, CX3CR1, and CD1c on Mf1 indicated that these cells were not PBMos co-isolated during tissue processing.

Human SI Mf compartment comprises short- and long-lived subsets that differ in marker expression {#s04}
------------------------------------------------------------------------------------------------

To assess the possibility that PBMos are precursors of intestinal Mfs, we first examined the expression of proteins that have been shown to be differently expressed on PBMos and Mfs ([@bib44]; [@bib4]). CCR2 and the antimicrobial protein calprotectin (heterodimer of S100A8 and S100A9) were uniformly expressed by CD14^+^ PBMos ([Fig. 2, A and B](#fig2){ref-type="fig"}). Nearly all Mf1 and Mf2 expressed both proteins, but their mRNA levels were reduced compared with CD14^+^ PBMos ([Fig. 2, A and B](#fig2){ref-type="fig"}). In contrast, only minor fractions of Mf3 and Mf4 expressed these markers ([Fig. 2, A and B](#fig2){ref-type="fig"}; and Fig. S2 A). CD209, reported as a marker of mature intestinal Mfs ([@bib40]), was present on Mf2 and both CD11c^−^ Mf subsets and was not detected on CD14^+^ PBMos or Mf1 ([Fig. 2 C](#fig2){ref-type="fig"}). However, we observed intermediate levels of *CD209* mRNA in Mf1 ([Fig. 2 C](#fig2){ref-type="fig"}).

![**Human SI Mf compartment comprises short- and long-lived subsets that differ in marker expression. (A)** The percentage of CCR2^+^ cells among CD14^+^ PBMo (*n* = 5) and SI Mf subsets (*n* = 10) was determined by flow cytometry (left). Gates were set according to FMO controls. The expression of *CCR2* mRNA was determined by RNaseq analysis; *n* = 5 (right). **(B)** The percentage of calprotectin^+^ cells among CD14^+^ PBMo (*n* = 7) and SI Mf subsets (*n* = 11) was determined by intracellular staining and flow cytometry. Gates were set according to staining with isotype control antibody. The expression levels of *S100A8* and *S100A9* mRNA were determined by RNaseq analysis; *n* = 5 (right). **(C)** The median fluorescence intensity (MFI) of CD209 relative to MFI of the FMO control on CD14^+^ PBMo (*n* = 5) and SI Mf subsets (*n* = 9) was determined by flow cytometry. The expression of *CD209* mRNA was determined by RNaseq analysis; *n* = 5 (right). (A--C, left) Bars represent median values; ns, not significant (*t* test comparing CD14^+^ PBMo and Mf1). \*, P \< 0.05; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001 (RM-ANOVA of SI subsets). (A--C, right) Expression values (log2FPKM) were mean-centered by transcript. **(D)** Representative flow cytometric analysis of recipient-specific HLA-A2 staining on Mf subsets from transplanted duodenum 6 wk after transplantation. Numbers on plots represent recipient^+^ cells (mean ± SD from all patients analyzed at this time point; *n* = 5). Gray histograms represent staining of HLA-DR^+^ stromal cells from the same sample. **(E)** The percentage of recipient-derived cells in each Mf subset at 3 (*n* = 6), 6 (*n* = 5), and 52 wk (*n* = 6) after transplantation was determined by flow cytometry. Bars indicate median values. \*, P \< 0.05; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001 (two-way ANOVA with RM on population).](JEM_20170057_Fig2){#fig2}

To directly examine whether human SI Mfs are dependent on PBMo recruitment, we next studied the replacement of duodenal Mfs after combined duodenum--pancreas transplantation in patients with diabetes mellitus (see Materials and methods and [@bib21] for details). Relying on a mismatch in HLA class I between donors and recipients, we could accurately determine the degree of chimerism of Mfs in biopsies from donor duodenum obtained 3, 6, and 52 wk after transplantation ([Fig. 2 D](#fig2){ref-type="fig"}). Only data from patients with no histological signs of rejection were included. As shown in [Fig. 2 E](#fig2){ref-type="fig"} almost all donor Mf1 and Mf2 cells were replaced by recipient cells within 3 wk after surgery, whereas in the CD11c^−^ Mf compartment only a minor fraction was of recipient origin (median 5.8% Mf3 and 3.4% Mf4). From 3 to 6 wk posttransplantation the fraction of recipient Mf3 and Mf4 increased to 17.7% and 21%, respectively, and at 52 wk posttransplantation all donor Mfs were replaced by recipient Mfs. Mf3 and Mf4 showed comparable replacement at the time points analyzed (Fig. S2 B). To determine whether surgical trauma or immunosuppressive regimen could influence Mf replacement, we examined the relative representation of subsets within the Mf compartment after transplantation. We found that at week 3 the proportion of Mf1 was increased with a corresponding reduction of Mf3 (Fig. S2 C). This was most likely the result of increased recruitment of PBMos caused by surgical trauma. Nevertheless, at 6 and 52 wk the cell subset ratios were similar to those observed in normal SI ([Fig. 1 B](#fig1){ref-type="fig"} and Fig. S2 C), suggesting that the observed Mf replacement at later time points represented a steady-state situation. Fluorescent in situ hybridization and immunofluorescence (IF) confocal microscopy of donor SI in gender-mismatched patients confirmed a normal distribution of Mfs in donor SI after surgery, as well as the persistence of donor Mfs at week 6 and their complete replacement 1 yr after transplantation (Fig. S2 D).

These experiments showed that human SI Mf compartment, likely derived from PBMos, consisted of short-lived Mf1 and Mf2 subsets and long-lived, more mature Mf3 and Mf4 subsets.

Mature Mf subsets localize to different compartments of the SI {#s05}
--------------------------------------------------------------

Observed similar replacement rates of Mf3 and Mf4 (Fig. S2 B) suggested that they are not subsequent stages of Mf differentiation but rather represent alternative pathways of Mf2 maturation in the intestine. To further determine the relationship between Mf3 and Mf4 subsets, we investigated their spatial localization in situ by IF microscopy. We observed CD209 expression on the majority of Mfs, but not on DCs ([Fig. 2 C](#fig2){ref-type="fig"} and Fig. S3 A; [@bib40]). CD209^+^ Mfs were observed throughout the mucosa (Fig. S3 B). CD209^+^CD11b^−^ Mf3 constituted the vast majority of Mfs in the upper crypt area and in the villi, whereas CD209^+^CD11b^+^ Mf4 were mainly situated below the crypts and in the submucosa ([Fig. 3, A and B](#fig3){ref-type="fig"}). We also observed CD209^+^ cells in the crypt area that coexpressed CD11b and CD11c, corresponding to an Mf2 phenotype ([Fig. 3 A](#fig3){ref-type="fig"}, inset c). Consistently, by physically separating the tissue at the level of muscularis mucosa before the digestion step, we found that Mf3 cells were enriched in the lamina propria and Mf4 in the submucosa ([Fig. 3 C](#fig3){ref-type="fig"}). Moreover, the vast majority of Mfs isolated from the muscle layer situated below the submucosa (muscularis propria) expressed an Mf4 phenotype ([Fig. 3 D](#fig3){ref-type="fig"}), indicating that Mf phenotype correlated with tissue localization.

![**Mature Mf subsets localize to different compartments of the SI. (A)** IF confocal micrograph from SI stained with CD209 (red), CD11c (blue), CD11b (green), and Hoechst DNA stain (gray). Dashed line marks the border between lamina propria and submucosa; bar, 50 µm. Individual channels from insets a, b, and c are displayed on the right; bars, 25 µm. Arrowheads (inset c) point to CD209^+^CD11c^+^CD11b^hi^ (orange) and CD11b^lo^ (white) Mf2 cells. The micrograph is representative of six individual subjects. **(B)** The percentage of Mf3 (CD209^+^CD11c^−^CD11b^−^) and Mf4 (CD209^+^CD11c^−^CD11b^+^) among total CD209^+^ cells in different compartments of intestinal mucosa as in A (*n* = 6). \*\*, P \< 0.01; \*\*\*, P \< 0.001 (two-way RM-ANOVA comparing localization). **(C)** The proportion of Mf3 and Mf4 calculated as percentage of all Mfs and DCs (CD45^+^HLA-DR^+^) was determined by flow cytometry in lamina propria and submucosa separated before the digestion step (*n* = 3). **(D)** Representative flow cytometric analysis of cells isolated from muscularis propria. Arrows indicate sequential gating. Dot plots are representative of five subjects.](JEM_20170057_Fig3){#fig3}

SI Mf subsets are distinguished by their gene expression patterns {#s06}
-----------------------------------------------------------------

To further define the SI Mf subpopulations, we performed low-cell RNA sequencing on sorted tissue Mfs and DCs, as well as CD14^+^ PBMos isolated from the same donors (*n* = 5, DCs were sorted from two of these). To effectively compare with Mfs, DCs were sorted into three subpopulations: CD103^+^SIRPα^−^ (single positive; SP-DC), CD103^+^SIRPα^+^ (double positive; DP-DC), and CD103^−^SIRPα^+^ (CD103^−^ DC; Fig. S4 A), as CD103^−^ DCs have been shown to be transcriptionally related to CD14^+^ PBMos ([@bib63]). Principal component analysis (PCA) of all subsets showed three main clusters of non-DC populations separated in component 1 (PC1, 23.35%; [Fig. 4 A](#fig4){ref-type="fig"}). CD14^+^ PBMos clustered separately from all SI Mfs. Mf1 was the Mf subset most similar to CD14^+^ PBMos, whereas Mf2, Mf3, and Mf4 clustered more together, indicating they were closely related. All DC subsets clustered together and were separated from CD14^+^ PBMos and Mfs in PC2 (9.24%). CD14^+^ PBMos pretreated with enzymes to control for effect of tissue digestion (PBMo-lib) clustered with the other CD14^+^ PBMo samples. We also included PBMo-differentiated Mfs (in vitro Mfs) in our analysis. PCA showed that in vitro Mfs clustered close to Mf1 and distant from the other Mf subsets and DCs ([Fig. 4 A](#fig4){ref-type="fig"}). However, in vitro Mfs were distant from Mf1 in PC3 (6.35%; Fig. S4 B). Pearson correlation analysis and hierarchical clustering of the total dataset were consistent with PCA in that CD14^+^ PBMos formed a separate cluster that displayed the highest degree of correlation with Mf1 among all subpopulations. Mf1 correlated well with Mf2 and less with Mf3 and Mf4. Mf2 essentially coclustered with Mf3 and Mf4. The three DC subsets formed a separate cluster, and DP-DC and CD103^−^ DC subsets showed some correlation with Mf2 ([Fig. 4 B](#fig4){ref-type="fig"} and Fig. S4 C). We validated our SI DC subset dataset by performing gene set enrichment analysis with recently published PBDC and PBMo subpopulation signatures obtained from single-cell RNA sequencing ([@bib62]). This showed that none of the subsets were enriched for PBMo signatures, and SP-DCs were closely related to conventional (c) DC1 whereas DP-DC and CD103^−^ DC were enriched for genes expressed by cDC2 and cDC1 (Fig. S4 D).

![**SI Mf subsets are distinguished by their gene expression patterns. (A)** PCA of top 1,000 differentially expressed genes within CD14^+^ PBMo, PBMo-lib (enzyme-treated CD14^+^ PBMos), SI Mf, and DC subsets and in vitro differentiated Mfs. **(B)** Pearson correlation and hierarchical clustering analysis of CD14^+^ PBMo, PBMo-lib, SI Mf, and DC subsets and in vitro Mfs. Fig. S4 D lists all correlation values. **(C)** Polytomous analysis of differentially expressed genes among CD14^+^ PBMo and SI Mf and DC subsets, grouped into 16 clusters based on top models obtained from unsupervised clustering. Genes were assigned to a model based on the highest calculated posterior probability value (\>0.65). Expression values are log2FPKM. Top-ranked genes from each cluster are listed on the right (full list available in Table S1). (A--C) CD14^+^ PBMos and SI Mfs were isolated from five donors, SI DC subsets from two of these. PBMo-lib were derived from two of the included CD14^+^ PBMo samples. In vitro Mfs were differentiated from PBMos of two separate healthy donors.](JEM_20170057_Fig4){#fig4}

We then performed a polytomous analysis to comprehensively analyze the transcriptomes of the different cell populations in relation to each other ([@bib59]). We used unsupervised hierarchical clustering on the whole dataset to identify top clusters and constructed the associated model matrices for subsequent analysis. By using Bayesian modeling, each gene was assigned to the most probable model based on the calculated posterior probability (\>0.65). We identified in total 6,735 differentially expressed genes for models with a common expression pattern in at least two cell subsets and grouped them by the corresponding model ([Fig. 4 C](#fig4){ref-type="fig"} and Tables S1 and S2).

CD14^+^ PBMos and Mf1 shared the largest number of highly expressed genes (cluster 1, *n* = 982; e.g., *RXRA*, *S100A8*), related to immune effector process and immune response gene ontology (GO) terms, among others ([Fig. 4 C](#fig4){ref-type="fig"} and Tables S1 and S2). Cluster 2 contained genes common to Mf2, CD14^+^ PBMos, and Mf1 (*n* = 171), although these were expressed at lower levels in the former (e.g., *MPO*, *VCAN*) and were related to biological processes corresponding to defense responses including cell activation and secretion. Cluster 3, common to Mf1 and Mf2, included 72 genes (e.g., *FN1*, *SPP1*) involved in cell signaling pathways. Mf1, Mf2, and Mf3 expressed common genes (cluster 4, *n* = 207), including *CCL18* and *CSF3*, related to, e.g., regulations of cell communication and protein phosphorylation. Cluster 5 (*n* = 809) was common to Mf2, Mf3, and Mf4 (e.g., *AHR*, *CFH*, *IL32*) and enriched for genes related to localization and cytokine--cytokine receptor interaction. Cluster 6 (*n* = 345) contained genes expressed in Mf3 and Mf4, which were annotated to terms involved in vesicle mediated transport and FCGR-dependent activation and phagocytosis. Cluster 7 (*n* = 365) comprised genes expressed in Mf1, DC subsets, and to a lesser extent Mf2 (e.g., *RPS20*, *EIF4B*, and many ribosomal protein genes), which were related to translation and RNA processing. Cluster 8 (*n* = 783) contained genes expressed in DC subsets that were associated with cell cycle and mitosis ([Fig. 4 C](#fig4){ref-type="fig"} and Tables S1 and S2).

In cluster 9 (*n* = 668), PBMos and Mf1 showed less cell cycle activity compared with other cell types. Several genes involved in the metabolism of carbohydrates were expressed in Mf3, Mf4, and DC subsets (cluster 10, *n* = 132). Clusters 11 and 12 (*n* = 29 and *n* = 158, respectively) comprised genes expressed in CD14^+^ PBMos, Mf4, and DC subsets, including those involved in chromatin organization (e.g., histone-coding genes). CD14^+^ PBMos, Mf1, and DC subsets shared cluster 13 (*n* = 832) comprising genes (e.g., *SPI1*, *MVP*, *BOD1L1*) involved in, e.g., response to hypoxia and many proteasome-related genes. Cluster 14 (*n* = 238) comprised genes expressed by CD14^+^ PBMos, Mf1, and DC subsets as well as Mf2 (e.g., *FGR*, *FYN*) related to cell activations processes, whereas CD14^+^ PBMos, Mf3, and Mf4 expressed genes (cluster 15, *n* = 296) annotated to GO terms such as cellular localization, organelle organization, and intracellular transport (e.g., *GOPC*, *STOML1*, *KIFAP3*). Lastly, cluster 16 (*n* = 663) contained genes that were expressed at higher levels in all Mf subpopulations and CD14^+^ PBMos compared with the DC subsets (e.g., *CD99*, *LAMP2*, *PL1*). These genes were involved in immune effector processes, exocytosis, and lysosomal function ([Fig. 4 C](#fig4){ref-type="fig"} and Tables S1 and S2).

Transcriptome profiling showed that SI Mfs comprised subpopulations with complex and partly overlapping expression profiles that were clearly distinct from SI DC subsets, CD14^+^ PBMos, and in vitro Mfs.

Specific gene expression in SI Mf and DC subsets {#s07}
------------------------------------------------

Next, we asked whether SI Mfs and DCs expressed subset-specific genes. After determining subset-specific clusters from polytomous analysis for each population, we identified genes expressed at minimum two fragments per kilobase of transcript per million mapped reads (FPKMs) and more than twofold higher than in all other tissue populations. In total 42 genes, including *S100A12*, could be attributed to Mf1 ([Fig. 5](#fig5){ref-type="fig"}). By applying these cut-offs, no specific gene signature was found for Mf2, and only two genes were identified for Mf3. For Mf4, we found 32 selectively expressed genes, including *CCL13*, *CCL11*, and several neuron-related genes (*LGI2*, *CCDC141*, *NPTX2*). Interestingly, this population also displayed highest expression of *BMP2* (Table S1), encoding bone morphogenetic protein 2 known to stimulate enteric neurons ([@bib35]). Only a few specific genes were identified for SIRPα^+^ DC subsets: four genes in DP-DCs and two genes in CD103^−^ DCs ([Fig. 5](#fig5){ref-type="fig"}). Lastly, we found 45 genes specifically expressed in SP-DCs, including cDC1-specific *XCR1* ([Fig. 5](#fig5){ref-type="fig"}; [@bib9]). The relatively few genes specifically expressed in Mf subpopulations further supported that these subsets were closely related.

![**Specific gene expression in SI Mf and DC subsets.** Mean expression values (log2FPKM) of genes found uniquely in a single SI Mf or DC subset in the polytomous analysis. Genes expressed at minimum 2 FPKM and more than twofold higher than in all other tissue populations were considered specific. SI Mfs were isolated from five donors, SI DC subsets from two of these.](JEM_20170057_Fig5){#fig5}

SI Mfs are highly proficient at antigen uptake {#s08}
----------------------------------------------

A crucial characteristic of Mfs is clearing debris and pathogens. To assess the ability of Mfs to phagocytose particulate material, we incubated SI cells and PBMCs with pHrodo green-labeled *Escherichia coli* particles. Among SI cells, Mf1 contained the highest percentage of pHrodo^+^ cells at all time points analyzed, whereas minor differences in phagocytic ability were observed among Mf2, Mf3, and Mf4 populations ([Fig. 6 A](#fig6){ref-type="fig"} and Fig. S5 A). All SI Mf subsets were less efficient than CD14^+^ PBMos but superior to DCs ([Fig. 6 A](#fig6){ref-type="fig"} and Fig. S5 A). Pre-incubation of *E. coli* particles with human serum before the assay strongly increased the percentage of pHrodo^+^ Mfs (opsonized), particularly Mf3 and Mf4, whereas it had little effect on phagocytosis by DCs ([Fig. 6 B](#fig6){ref-type="fig"}).

![**SI Mfs are highly proficient at antigen uptake. (A)** The percentage of pHrodo green *E. coli*^+^ cells among CD14^+^ PBMo, PBDC (left, *n* = 5), and SI Mf subsets and DCs (right, *n* = 5) was determined by flow cytometry after indicated incubation times. **(B)** The effect of preincubation with human serum (opsonization) on the uptake of pHrodo green *E. coli* bioparticles by SI Mf subsets and DCs was determined by flow cytometry after 15 or 45 min of incubation (*n* = 5). *E. coli* bioparticles were opsonized by incubating in 50% inactivated human serum for 30 min at 37°C. \*, P \< 0.05; \*\*\*\*, P \< 0.0001 (two-way RM-ANOVA comparing effect of opsonization at one time point). **(C)** The percentage of DQ-OVA (green)^+^ cells among CD14^+^ PBMo, PBDC (left, *n* = 5), and SI Mf subsets and DCs (right, *n* = 5) was determined by flow cytometry after indicated incubation times. (A and C) Data are presented as mean ± SEM of pHrodo^+^ (A) or DQ-OVA^+^ (C) cells within each population (Fig. S4 A). Comparisons between subsets are marked in color corresponding to compared subset. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001 (two-way RM-ANOVA).](JEM_20170057_Fig6){#fig6}

Next, to assess endocytosis and intracellular proteolysis of protein antigens, we incubated cells with fluorochrome-conjugated ovalbumin (DQ-OVA), which emits green fluorescence after proteolysis in lysosomes. Mf1, Mf2, and Mf3 captured and processed DQ-OVA comparably to CD14^+^ PBMos and better than Mf4 ([Fig. 6 C](#fig6){ref-type="fig"}). Tissue-derived DCs appeared to be less efficient than Mfs ([Fig. 6 C](#fig6){ref-type="fig"}). Previous studies have shown that ovalbumin can be taken up by several pathways, including mannose receptor (CD206)-mediated endocytosis, scavenger receptor--mediated endocytosis, and pinocytosis ([@bib7]). Analysis of the gene expression data showed that several genes related to endocytosis and lysosomes were differently expressed both among Mf subsets and between Mfs and DCs (Fig. S5 B).

This showed that all Mf subsets can efficiently endocytose both particulate and soluble material and indicated that SI Mfs and DCs may use different pathways for antigen uptake and processing.

SI Mfs have attenuated cytokine production {#s09}
------------------------------------------

Mfs can have both immunosuppressive and immune activating properties depending on signals from the microenvironment ([@bib10]). We therefore examined spontaneous and LPS-induced secretion of both proinflammatory and immunosuppressive cytokines and chemokines from sorted CD14^+^ PBMos, SI Mf subsets, and DCs. Unstimulated Mf1 secreted significantly higher amounts of all cytokines and chemokines compared with the other tissue-derived subsets and CD14^+^ PBMos ([Fig. 7 A](#fig7){ref-type="fig"}). After stimulation with LPS for 21 h, Mf1 further increased secretion of TNFα, IL-1β, IL-6, IL-10, and GM-CSF but produced significantly less CCL2 and IL-8. In contrast, the other subsets showed no significant response to LPS other than an increase in IL-8 production by DCs ([Fig. 7 B](#fig7){ref-type="fig"}). The effect of LPS on cytokine secretion by Mf1 was very modest (median fold change of 1.11--1.45 for cytokines with increased secretion, 0.55 for CCL2, and 0.90 for IL-8) and much less pronounced than that observed for LPS-stimulated CD14^+^ PBMos and PBMo-lib ([Fig. 7 C](#fig7){ref-type="fig"}). Pretreating PBMos with Liberase did not affect cytokine secretion ([Fig. 7, A and C](#fig7){ref-type="fig"}).

![**SI Mfs have attenuated cytokine production. (A)** Spontaneous cytokine release by sorted SI Mf subsets and DCs (*n* = 8) and CD14^+^ PBMos and PBMo-lib (*n* = 7) was measured by a Bio-Plex assay in supernatants after 21 h of culture. Bars indicate median values. ^\#^, P \< 0.05; ^\#\#^, P \< 0.01; ^\#\#\#^, P \< 0.001; ^\#\#\#\#^, P \< 0.0001 (ANOVA of PBMo, PBMo-lib, and Mf1). \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001 (RM-ANOVA of SI subsets). **(B)** Concentration of cytokines released spontaneously (dots) and after stimulation with 1 µg/ml LPS (squares) in supernatants after 21 h of culture of sorted SI Mf subsets and DCs (*n* = 5). \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001 (two-way RM-ANOVA). **(C)** Concentration of cytokines released spontaneously (dots) and after stimulation with 1 µg/ml LPS (squares) in supernatants after 21 h of culture of sorted CD14^+^ PBMos and PBMo-lib (*n* = 6 or 7). \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001 (two-way RM-ANOVA). **(D)** The percentage of TNFα^+^ cells in SI Mf subsets was determined by intracellular staining and flow cytometric analysis after 4 h of culture in medium only or containing LPS, flagellin, R848, or poly(I:C) (*n* = 3). Floating bars represent range, with a line indicating median. Dotted line represents background staining on Mf3 and Mf4 based on the fraction of cells found within the isotype control gate. \*, P \< 0.05; \*\*, P \< 0.01 compared with matched medium-only control (two-way RM-ANOVA).](JEM_20170057_Fig7){#fig7}

We examined the effect of other TLR ligands by measuring production of TNFα by intracellular flow cytometry after 4 h of stimulation. Consistent with the results above ([Fig. 7, A--C](#fig7){ref-type="fig"}), a small fraction of unstimulated Mf1 produced TNFα, which increased significantly in presence of LPS ([Fig. 7 D](#fig7){ref-type="fig"}). Similarly, stimulation with poly(I:C), flagellin, and R848 significantly increased the fraction of Mf1 expressing TNFα. Mf2 responded to stimulation to a lesser extent compared with Mf1, whereas Mf3 and Mf4 did not respond to any of the TLR ligands tested ([Fig. 7 D](#fig7){ref-type="fig"}).

Discussion {#s10}
==========

Phenotypic heterogeneity of the Mf compartment has been previously shown in human duodenum ([@bib3], [@bib4]), ileum ([@bib1]), and colon ([@bib37]). Here, we showed that in human duodenum--proximal jejunum four distinct Mf subpopulations could be identified using only HLA-DR, CD14, CD11c, and CD11b expression. Based on surface marker expression, Mf1 cells were comparable with CD14^hi^HLA-DR^lo^CD209^lo^CD163^lo^, Mf2 with CD14^hi/lo^HLA-DR^hi^CD209^lo^CD163^lo^CD11c^+^, Mf3 with CD14^lo^HLA-DR^hi^CD209^hi^CD163^hi^, and Mf4 with CD14^hi^HLA-DR^hi^CD209^hi^CD163^hi^ cells described in terminal ileum ([@bib1]). By using functional and transcriptional analyses, we extended these findings showing that the SI Mf compartment comprised cells with PBMo-like features as well as spatially distinct mature Mf subsets that were hyporesponsive to inflammatory stimuli but highly endocytic.

Studies in mice have shown that PBMos constitutively enter the intestine and replace mature Mfs through a gradual differentiation process ([@bib58]; [@bib1]; [@bib48]). In transplanted human duodenum, all Mfs were replaced by recipient cells within one year. Mf1 and Mf2 were most rapidly replaced (most within 3 wk) after transplantation and had a phenotype and morphology that resembled PBMos. However, transcriptional profiling showed that Mf1 were most similar to PBMos whereas Mf2 were more similar to Mf3 and Mf4, indicating that Mf1 were most recently elicited and Mf2 an intermediary differentiation stage between Mf1 and Mf3/4. Mf3 and Mf4 were more slowly replaced in duodenal transplants, had a typical mature Mf morphology, and were more autofluorescent compared with Mf1 and Mf2. Moreover, expression of markers that are typically related to PBMos (CCR2 and calprotectin) and mature Mfs (CD209) was gradational between the Mf subsets. Although we cannot definitively exclude the possibility that circulating precursor cells other than PBMos can give rise to intestinal Mfs in humans, our data suggest that the Mf compartment in human SI comprises a continuum of cells derived from PBMos, differentiating through intermediary Mf1 and Mf2 into Mf3/4, similar to that reported for Mfs in mouse intestine ([@bib58]; [@bib1]).

Mf3 and Mf4 were both slowly replaced in duodenal transplants and showed compartmentalized localization in the tissue, suggesting they represented alternative pathways of Mf differentiation in SI. Mf3 comprised the majority of SI Mfs and formed a dense network throughout the villous mucosa, resembling the steady-state resident CX3CR1^hi^ mouse intestinal Mfs ([@bib24]). In contrast, CD11b^+^ Mf4 were primarily located deep in the mucosa and in the submucosa. Additionally, cells expressing Mf4 phenotype constituted the majority of Mfs in muscularis propria. Submucosa and muscularis propria are densely innervated, and studies in mice have shown that Mfs in muscularis propria are functionally different from lamina propria Mfs and interact with enteric nervous system ([@bib35]; [@bib13]). Moreover, expression of CD11b on microglia has been shown to be important for synaptic pruning ([@bib55]). Mf4 preferentially expressed *BMP2*, suggesting they may be homologous to mouse muscularis Mfs ([@bib35]).

Mfs and DCs both belong to the mononuclear phagocyte system, share several functional properties (e.g., antigen presentation), and express common surface markers. Consequently, such cells have often been inappropriately identified in the literature ([@bib8]; [@bib15]), although recent advancements in fate mapping and tracing experiments have helped define tissue DCs and Mfs in mice ([@bib16]; [@bib15]). Our analysis of DC and Mf transcriptomes clearly showed that SI DC subsets were distinct from SI Mf subsets and PBMos. Comparing our data with a recent study on PBDC and PBMo subsets ([@bib62]), we corroborated the findings of [@bib63] that SP-DCs correlated with cDC1 and DP-DCs with cDC2. In contrast to Watchmaker et al., we did not observe enrichment for PBMo-related gene signatures in CD103^−^ DCs; however, whether CD103^−^ DCs included PBMo-derived cells was impossible to determine from these analyses.

Mfs are believed to play an essential role at mucosal sites, both to respond to and eliminate infectious organisms and to maintain homeostasis by clearance of debris and dead cells ([@bib10]). Here we showed that all Mf subsets were very efficient at endocytosis of both particulate and soluble material. Consistently, transcriptional analysis showed that Mf2, Mf3, and Mf4 were enriched for genes involved in endocytosis, receptor-mediated phagocytosis, and lysosome function (clusters 5 and 6). Further, mucosal Mfs were more efficient than DCs in uptake and processing of soluble antigen (ovalbumin). This is consistent with a previous study showing that SI CX3CR1^+^ Mfs, but not CD103^+^ DCs, can efficiently capture luminal ovalbumin in mice ([@bib31]). SI DCs and Mfs expressed different genes related to endocytosis and lysosome GO terms, which is difficult to correlate with our functional data, but suggests a level of specialization in uptake and processing of antigens between these cell types. In contrast to previous studies ([@bib53]; [@bib1]), we observed increased phagocytosis in PBMos compared with SI Mf subsets. This discrepancy may be because of inherent differences between SI and colon Mfs, species, or differences in the method used.

Mf1 secreted low levels of cytokines without stimulation but responded most strongly to TLR ligands among SI subsets. This may suggest that PBMo extravasation through endothelium induces a "poised" state of cellular activation ([@bib57]; [@bib64]). Mf1 responded less strongly to LPS stimulation than PBMos, and both spontaneous cytokine production and responsiveness to TLR stimulation were further reduced in Mf2, whereas Mf3 and Mf4 did not respond to any of the TLR ligands tested. This apparent hyporesponsiveness suggests that maturation of Mfs in the intestine could induce an increased threshold for TLR-mediated activation. The poised activation state and opsonization-independent high phagocytic activity of Mf1 suggest their potential role in responding to events that disturb intestinal homeostasis. However, as high levels of proinflammatory cytokines could lead to destruction of tissue integrity ([@bib36]), the lack of cytokine production and hyporesponsiveness to stimulation in Mf3 is likely necessary to maintain homeostasis in the intestinal mucosa and an integral part of resident intestinal Mf identity.

An essential role of IL-10 in maintenance of intestinal homeostasis has been demonstrated in studies of *Il10*^−/−^ mice that develop spontaneous enterocolitis ([@bib27]; [@bib5]; [@bib30]). In humans, the importance of IL-10 is indicated by loss-of-function variants of *IL-10R* that cause severe early-onset inflammatory bowel disease ([@bib14]; [@bib30]; [@bib51]). IL-10 can be produced by various leukocytes, including Mfs ([@bib25]). We observed neither spontaneous nor induced IL-10 production in mature SI Mfs, which is consistent with previous studies reporting a lack of IL-10 production by human jejunal Mfs ([@bib53], [@bib54]). In contrast, colonic Mfs have been shown to produce IL-10 in humans ([@bib23]; [@bib37]) and in mice ([@bib42]; [@bib1]; [@bib26]). Because IL-10^+^ Mfs are more frequent in the mouse colon compared with SI ([@bib26]), it is possible that regulation of IL-10 production differs between these compartments. A recent study indicated that the capacity of Mfs to respond to, rather than produce, IL-10 is important to maintain intestinal homeostasis ([@bib67]).

Multiple studies probing the function of human Mfs have often used PBMos matured in vitro as surrogates for tissue Mfs. Interestingly, our transcriptional analysis showed that in vitro Mfs separated from all SI Mf subsets. This finding further underscores the importance of microenvironmental factors in differentiation of tissue resident Mfs, especially considering the spectrum of responsiveness of the PBMo-derived cells to various stimuli ([@bib66]). It is likely that PBMo-to-Mf differentiation in the intestinal mucosa involves multiple factors in the microenvironment ([@bib38]; [@bib22]).

Together, our results support a model where PBMos constitutively migrate into the intestinal mucosa where they gradually lose their proinflammatory capacity and, via sequential short-lived intermediaries (Mf1 and Mf2), differentiate into the mature Mf3 or Mf4, likely depending on tissue-specific signals in the microenvironment. This study provides an important basis for future research on human intestinal Mfs, including their contribution to inflammation, wound healing, and other pathological changes in the intestine.

Materials and methods {#s11}
=====================

Patients {#s12}
--------

Tissue samples of human SI were obtained from patients with pancreatic cancer, distal bile duct cancer, or periampullary carcinoma undergoing the Whipple procedure (pancreaticoduodenectomy; *n* = 95, mean age 68 yr, range 39--88 yr, 43 women). Material analyzed was the distal part of resected SI (duodenum--proximal jejunum) from patients without metastases, who had not undergone previous oncological treatment.

Tissue samples from transplanted duodenum were obtained from patients (*n* = 15) with diabetes mellitus type I who had received pancreas--duodenal segment transplantation either singly or in combination with kidney transplantation. All recipients received standard immunosuppressive regimen ([@bib21]). Biopsies from donor duodenum were obtained at 3, 6, and 52 wk posttransplantation. Grading of acute cellular rejection was performed at weeks 3 and 6 by an experienced pathologist according to [@bib46], and only patients without signs of cellular rejection were included (*n* = 11).

Buffy coats and blood were collected from healthy donors and patients undergoing the Whipple procedure.

The study was approved by the Norwegian Regional Committee for Medical Research Ethics, and all patients gave written informed consent.

Tissue handling and cell isolation {#s13}
----------------------------------

Pieces of SI obtained from the Whipple procedure were opened longitudinally and washed in PBS. Mucosa was dissected in narrow strips from underlying fat and muscle tissue and then incubated with shaking in PBS with 2 mM EDTA (Sigma-Aldrich) and 1% FCS (Sigma-Aldrich) three times for 15 min at 37°C. Epithelial cells were removed after each incubation step by filtration through nylon 100-µm mesh. Where stated, after epithelial cell removal, lamina propria was isolated by tearing off of the underlying submucosa under a microscope, and the two compartments were processed separately from this point onward. Tissue was minced and digested with stirring for 60 min in complete RPMI (RPMI1640; Lonza; supplemented with 10% FCS, 1% Pen/Strep; Lonza) containing 0.25 mg/ml Liberase TL (Roche) and 20 U/ml DNase I (Sigma). Digested cell suspension was passed through a 100-µm filter and washed. Mucosal biopsies obtained from transplanted patients were processed according to the same protocol, starting with EDTA washes. Where stated, CFSE-labeled CD14^+^ PBMos were added to tissue pieces before the digestion step. PBMCs were isolated by density centrifugation over Lymphoprep (Axis-Shield).

Antibodies {#s14}
----------

The following antibodies were used for flow cytometry. CD1c-PE (L161), CD11b-APC/BV421/BV650 (ICRF44), CD14-APC-Cy7/PacBlue/PE-Cy7/AF700 (HCD14), CD16-PE/AF700 (3G8), CD45-BV510/AF700/APC-Cy7 (HI30), CD64-PE-Cy7 (10.1), CD115-PE (9-4D2-1E4), CD163-APC/PE (GHI/61), SIRPα-PE-Cy7 (SE5A5), CCR2-BV421 (K032C2), CX3CR1-PE (2A9-1), HLA-DQ-FITC/PE (HLADQ1), and HLA-DR-BV605/PerCP-Cy5.5/PE-Cy7 (L243) were from BioLegend. CD11c-PE/APC (S-HCL-3), CD45-APC-H7 (2D1), and CD209-APC (DCN46) were from BD Biosciences. MerTK-PE (125518) was from R&D Systems. CD103-PE (B-Ly7) and TNFα-AF488 (Mab11) were from eBioscience. Calprotectin-PE (MAC387) was from AbD Serotec. Unconjugated CD206 (19.2) was from BD Biosciences and was used with secondary goat anti--mouse IgG1-PE from Southern Biotech. FcR blocking reagent (Miltenyi Biotec) was added with antibodies during staining of surface and intracellular antigens to reduce background staining.

Donor- and recipient-derived cells were distinguished by using HLA-A2-PE (BB7.2) from Abcam, HLA-A3-APC/FITC (GAP.A3) from eBioscience, HLA-B7-PE (BB7.1) from Millipore, and HLA-B8-PE (REA145) from Miltenyi Biotec.

The following unconjugated (unless otherwise stated) primary antibodies were used for microscopy: CD11b (2LPM19c; Thermo Scientific), CD11c (CBR-p150/4G1; AbD Serotec), CD163 (10D6; Leica), CD209-APC (DCN46; BD Biosciences), CD209/DC-SIGN (5D7; Abcam), CD68 (PG-M1; DAKO), and HLA-DRα (TAL.1B5; DAKO). Polyclonal rabbit IgG targeting calprotectin was a gift from I. Dahle (Calpro, Oslo, Norway). The following secondary goat antibodies were used: anti--mouse IgG1-AF488/AF555/AF647, anti--mouse IgG2a-AF555, anti--mouse IgG3-AF594, and anti--rabbit IgG-AF555 (Invitrogen) and anti--mouse IgG2b-AF647, anti--rabbit IgG-AF488, and donkey anti--rabbit IgG-AF647 (Molecular Probes).

Flow cytometry {#s15}
--------------

Cells were stained with fluorescently labeled antibodies (previous section) on ice for 15 min. HLA allotype-specific antibodies were used to distinguish donor and recipient cells in the transplanted intestinal tissue. Donor-specific staining on stromal cells was confirmed in each experiment. Doublets were discriminated in forward scatter area versus height (FSC-A/FSC-H) and side scatter area versus width (SSC-A/SSC-W) plots. Dead cells were excluded based on propidium iodide, TO-PRO-1, or TO-PRO-3 staining (Molecular Probes). BD Cytofix/Cytoperm kit (BD Biosciences) was used for intracellular staining and Foxp3/Transcription Factor Staining Buffer Set (eBioscience) for intranuclear staining, and dead cells were excluded by staining with fixable viability dyes in eFluor 450 or eFluor 780 (eBioscience). Flow cytometry was performed on BD LSRFortessa (BD Biosciences), and data were analyzed with FlowJo software.

Cell sorting {#s16}
------------

For cytokine immunoassay and morphology assessment, SI cells were first enriched by using 10 µg/ml anti--HLA-DQ antibody (clone FN81; BMA Biomedicals) biotinylated with DSB-X Biotin Protein Labeling kit (Molecular Probes) and Dynabeads FlowComp Flexi kit (Invitrogen). Remaining CD14^+^ cells were sorted from the HLA-DQ^−^ fraction with Dynabeads FlowComp Human CD14 kit (Invitrogen). Bead-free HLA-DQ^+^ and HLA-DQ^−^CD14^+^ cells were stained as described in the previous section, and subpopulations were sorted on FACSAria IIu (BD Biosciences): Mf1 from HLA-DQ^−^CD14^+^, other Mf subsets and total DCs from HLA-DQ^+^ fraction. For cytokine immunoassay and generation of CFSE-monocytes, CD14^+^ PBMos were sorted from PBMCs (where specified after incubation with Liberase TL and DNase I as described in the Tissue handling and cell isolation section) with CD14 MicroBeads (Miltenyi Biotec). For RNA sequencing, SI cell suspension was first separated with CD14 MicroBeads, and Mf subsets (*n* = 5) were sorted from CD14^+^ fraction (0.3--1.25 × 10^5^ cells per subset) on FACSAria IIu. CD14^−^ fraction was further enriched for DC by removing CD3^+^, CD19^+^, and CD38^+^ cells by using CD3 Dynabeads (Invitrogen), Pan Mouse IgG Dynabeads (Invitrogen) precoated with unconjugated anti-CD19 (clone HIB19 from BioLegend), and anti-CD38 (clone HB7 from Absolut Antibody LTd) antibodies as described in the Dynabeads manufacturer's protocol (Direct Technique). 1.15--4.2 × 10^4^ cells per DC subset were sorted on FACSAria IIu (*n* = 2). All cells were sorted into complete RPMI, washed in PBS, then lysed in 80 µl RLT buffer (QIAGEN RNeasy Micro) containing 1% β-mercaptoethanol (Sigma) and stored at −80°C until use. CD14^+^ PBMos from the same donors were sorted from PBMCs by using the Dynabeads Untouched Human Monocytes kit (Invitrogen) where stated, including enzymatic treatment as in the Tissue handling and cell isolation section. 0.4--1.6 × 10^5^ CD14^+^ PBMos have been lysed in 80 µl RLT buffer containing 1% β-mercaptoethanol and stored at −80°C until use.

Microscopy {#s17}
----------

To assess morphology, 2.5--5 × 10^4^ sorted cells were spun onto a glass slide, fixed, and stained with a Hemacolor stain kit (Merck). Cytospins were viewed by using Olympus BX51 microscope with ColorView IIIu camera (Olympus).

For combined fluorescence in situ hybridization (FISH)/IF, formalin-fixed biopsies were cut at 4 µm, and sections were mounted on slides and incubated overnight at 56°C. Specimens were then dewaxed in xylene, rehydrated in ethanol, and boiled for 20 min in Dako buffer. Sections were incubated with CEP X/Y DNA probes (Abbott Molecular) overnight at 37°C and subsequently stained with antibodies (Antibodies section) according to standard protocol in 1.25% BSA. For IF only, cut sections were boiled in citrate buffer or stained immediately after thawing (sections from cryopreserved biopsies), and staining with secondary antibodies was performed in presence of 10% human serum. Nuclei were counterstained with Hoechst 33258 (Molecular Probes). Images were acquired on an Olympus FV1000 (BX61WI) system with 405-, 488-, 543-, and 633-nm laser lines by using 20×/0.80 or 60×/1.35 UPlanSApo oil objectives (Olympus).

Immunoenzymatic staining for CD209 was performed on formalin-fixed 4-µm sections, dewaxed in xylene and rehydrated in ethanol, by using EnVision FLEX, High pH (Dako Autostainer/Autostainer Plus) and the HRP kit (DAKO), following manufacturer's instructions. In brief, heat-induced antigen retrieval was performed in Tris/EDTA pH9 buffer, followed by peroxidase blocking, staining with primary antibody (anti--DC-SIGN, clone 5D7, 10 µg/ml) for 60 min at room temperature, secondary HRP-conjugated antibody for 30 min at room temperature, and incubation with substrate (DAB) for 7 min at room temperature, with wash steps in between. Slides were then stained with hematoxylin and eosin and scanned by using Pannoramic Midi slide scanner (3DHISTECH).

Cytokine measurement {#s18}
--------------------

1.5--3 × 10^4^ SI cells or CD14^+^ PBMos, sorted into populations as described, were cultured in 200 µl complete RPMI in 96-well round bottom plates for 21 h at 37°C with or without 1 µg/ml LPS (Sigma). Cells and debris were removed by centrifugation, and collected supernatants were kept at −80°C until use. Measurement of TNFα, IL-1β, IL-6, IL-8, IL-10, IL-12p70, GM-CSF, CCL2, and CCL4 in culture supernatants was done with a custom premixed Bio-Plex assay (Bio-Rad). Cytokine concentrations in the supernatants were normalized by multiplying the obtained concentrations by a factor equal to 3 × 10^4^/x, where x is the number of cells plated in a given well. For flow cytometry assay, 5 × 10^6^ SI cells were cultured for 4 h in complete RPMI in ultra-low attach plates and treated with LPS, 1 µg/ml flagellin (InvivoGen), 5 µg/ml poly(I:C) (Sigma), or 1 µg/ml R848 (Tocris Bioscience). Cytokine secretion was blocked with GolgiStop (BD Biosciences) added 30 min after start of the culture.

Assessment of antigen uptake {#s19}
----------------------------

3 × 10^6^ cells were incubated with 50 µg/ml DQ-OVA (Molecular Probes) or with 1 mg/ml pHrodo Green *E. coli* bioparticles (Molecular Probes) for specified times at 37°C or on ice. Where stated, pHrodo Green *E. coli* bioparticles were opsonized by incubation in 50% inactivated human serum for 30 min at 37°C, washed, and resuspended in fresh serum-free buffer before the assay. After incubation, cells were washed, stained with antibodies, and analyzed by flow cytometry by comparing fractions of green fluorescent cells incubated at 37°C and on ice for the same amount of time.

In vitro Mfs {#s20}
------------

Differentiation was performed as described ([@bib47]). In brief, buffy coats were obtained from Sanquin in Radboudumc. PBMCs were isolated by double gradient centrifugation, first over Ficoll-Paque Plus (GE Healthcare Life Sciences) and following centrifugation over hyper osmotic Percoll solution (GE Healthcare Life Sciences). T, B, and NK cells were depleted by selection with CD3, CD19, and CD56 MicroBeads on LD columns (Miltenyi Biotec) and PBMos were further enriched by attachment to plastic after culture in RPMI 1640 supplemented with 1% Pen/Strep and 10% human serum (Sigma Aldrich) as a source of M-CSF, for 1 h at 37°C and 5% CO~2~ and removal of floating cells. Mfs were obtained after culturing PBMos for 7 d with a change of medium every 3 d.

RNA isolation and library construction {#s21}
--------------------------------------

For RNA sequencing SMART-seqII protocol was used as described before ([@bib39]). In brief, total RNA was isolated by using a column-based kit according to manufacturer's instruction (RNeasy Micro; QIAGEN). RNA with good quality, as assessed by Experion Automated Electrophoresis System (Bio-Rad), was used for cDNA synthesis by using ultra-low input RNA SMART-seq v4 kit according to the manufacturer's protocol (Clonetech). Diagenode Pico sonicator was used to shear cDNA, and the sonication efficiency was evaluated by a 2100 Bioanalyzer (Agilent). A KAPA Hyper Prep kit (KAPA Biosystems) was used to make libraries for next-generation sequencing by using standard Illumina library prep protocol. In brief, sonicated cDNA was end repaired and A-tailed in one reaction for 30 min at 20°C followed by deactivation of the enzyme by heating to 65°C for another 30 min. Then NextFlex ChIP-seq adapters (Bioo Scientific) were used to barcode the end-repaired A-tailed samples at 20°C for 15 min. Ligated samples were cleaned by using AMPure XP beads (Beckman Coulter) with the sample:bead ratio of 0.8 to remove remaining enzymes and adapters. The libraries were amplified for 10 PCR cycles (HIFI HotStart kit; KAPA), cleaned with QIAquick PCR purification kit (QIAGEN), and subjected to size selection by using the E-Gel electrophoresis system size selection approach (Thermo Fisher Scientific) to select 300 bp fragments. Libraries were concentrated by using vacuum centrifugation (Savant DNA SpeedVac; Thermo). Library concentration was quantified by Qubit 2 (Thermo Fisher Scientific), and the average size of the libraries was determined by the 2100 Bioanalyzer. Sequencing was performed on Illumina NextSeq 500 platform with paired-end reads and a sequencing depth of 35 million reads per end.

Analysis of RNaseq data {#s22}
-----------------------

Raw data were cleaned from ribosomal RNA contamination by using Bowtie ([@bib28]), and the reads with quality score \>15 were chosen for subsequent analysis. Processed reads were aligned to human genome (hg19) by using Bowtie ([@bib65]) with default options, and the expression values were used to remove the possible sample batch effects as described before ([@bib29]). The polytomous analysis was performed by using MMSEQ pipeline ([@bib59]) with default options. The functional analysis was performed by using g:Profiler ([@bib41]). For GO and pathway analysis we used the Gene Ontology consortium database and KEGG and REACTOME databases, respectively. Gene set enrichment analysis was performed by using Broad Institute GSEA software ([@bib33]; [@bib56]). All other analyses were performed in R and Linux.

Statistical analysis {#s23}
--------------------

All statistical analyses were performed by using Prism 6.0 (GraphPad Software). Data were analyzed by two-tailed Student's *t* test, Mann-Whitney test, one-way ANOVA (standard, or repeated measures, RM-ANOVA), followed by Tukey's multiple comparison tests, or two-way RM-ANOVA followed by Šídák's multiple comparison tests. Values of P \< 0.05 were considered significant.

Accession numbers {#s24}
-----------------

Sequencing raw data of this study has been deposited under a controlled data access at the European Genome-phenome Archive (<http://www.ebi.ac.uk/ega/>), which is hosted at the EBI, under accession no. [EGAS00001002093](https://www.ebi.ac.uk/ega/studies/EGAS00001002093).

Online supplemental material {#s25}
----------------------------

Fig. S1 includes the extended gating of SI Mf subsets and DCs, CD14^+^ PBMos, and PBDCs, CD14 MicroBeads separation of PBMCs, and phenotype comparison of CFSE-PBMos and Mf1. Fig. S2 (related to [Fig. 2](#fig2){ref-type="fig"}) shows phenotype comparison of Mf2, Mf3, and CCR2^+^ Mf3 fraction and additional data related to Mf replacement, including correlation of Mf3 and Mf4 replacement, representation of Mf subsets in transplant material, and FISH/IF micrographs showing Mf replacement at 6 and 52 wk in sex-mismatched transplanted duodenum. Fig. S3 (related to [Fig. 3](#fig3){ref-type="fig"}) shows CD209 expression in SI. Fig. S4 (related to [Fig. 4](#fig4){ref-type="fig"}) includes representation of SI DC subsets, PC3 in relation to PC1 and PC2, and gene set enrichment analysis of PBDC and PBMo subset signatures in SI DC subsets. Fig. S5 (related to [Fig. 6](#fig6){ref-type="fig"}) explains gating of pHrodo^+^ populations in uptake assays and includes heatmaps of endocytosis and lysosome-related genes expressed in SI subsets. Table S1 (related to [Fig. 4](#fig4){ref-type="fig"}) lists genes included in clusters 1--16. Table S2 (related to [Fig. 4](#fig4){ref-type="fig"}) includes GO terms and pathways enriched in clusters 1--16. Tables S1 and S2 are included as Excel files.
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